Walleye Trading’s iShares Biotechnology ETF IBB Stock Holding History

Walleye Trading’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$996K	Sell	5,900 -31,200	-84%	-$5.34M	﹤0.01%	2168
2025 Q4	$6.26M	Buy	37,100 +20,400	+122%	+$3.31M	0.01%	1165
2025 Q3	$2.41M	Buy	16,700 +5,300	+46%	+$723K	﹤0.01%	1702
2025 Q2	$1.44M	Buy	+11,400	New	+$1.4M	﹤0.01%	1942
2025 Q1	–	Sell	-15,100	Closed	-$2M	–	4331
2024 Q4	$2M	Sell	15,100 -2,500	-14%	-$351K	﹤0.01%	1703
2024 Q3	$2.56M	Buy	17,600 +9,500	+117%	+$1.37M	0.01%	1525
2024 Q2	$1.11M	Buy	8,100 +2,500	+45%	+$334K	﹤0.01%	1994
2024 Q1	$768K	Buy	5,600 +100	+2%	+$13.7K	﹤0.01%	2460
2023 Q4	$747K	Buy	5,500 +5,300	+2,650%	+$647K	﹤0.01%	2730
2023 Q3	$24.5K	Sell	200 -1,800	-90%	-$229K	﹤0.01%	4352
2023 Q2	$254K	Buy	2,000 +700	+54%	+$90.9K	﹤0.01%	3281
2023 Q1	$168K	Sell	1,300 -10,200	-89%	-$1.34M	﹤0.01%	3630
2022 Q4	$1.51M	Buy	11,500 +6,300	+121%	+$814K	﹤0.01%	1902
2022 Q3	$608K	Sell	5,200 -10,000	-66%	-$1.24M	﹤0.01%	2715
2022 Q2	$1.79M	Buy	15,200 +4,700	+45%	+$558K	0.01%	1768
2022 Q1	$1.37M	Sell	10,500 -1,500	-13%	-$195K	﹤0.01%	1971
2021 Q4	$1.83M	Sell	12,000 -2,700	-18%	-$418K	0.01%	1717
2021 Q3	$2.38M	Buy	14,700 +14,300	+3,575%	+$2.41M	0.01%	1464
2021 Q2	$65K	Sell	400 -600	-60%	-$92.4K	﹤0.01%	4535
2021 Q1	$151K	Sell	1,000 -42,100	-98%	-$6.69M	﹤0.01%	3857
2020 Q4	$6.53M	Buy	43,100 +1,500	+4%	+$214K	0.03%	583
2020 Q3	$5.63M	Sell	41,600 -3,700	-8%	-$502K	0.03%	510
2020 Q2	$6.19M	Sell	45,300 -10,900	-19%	-$1.39M	0.04%	436
2020 Q1	$6.05M	Buy	56,200 +30,400	+118%	+$3.5M	0.05%	330
2019 Q4	$3.11M	Buy	25,800 +11,200	+77%	+$1.25M	0.02%	883
2019 Q3	$1.45M	Sell	14,600 -7,000	-32%	-$733K	0.01%	1318
2019 Q2	$2.36M	Sell	21,600 -7,300	-25%	-$776K	0.02%	926
2019 Q1	$3.23M	Sell	28,900 -10,100	-26%	-$1.11M	0.03%	748
2018 Q4	$3.76M	Sell	39,000 -26,500	-40%	-$2.81M	0.03%	631
2018 Q3	$7.99M	Buy	65,500 +50,200	+328%	+$5.91M	0.04%	424
2018 Q2	$1.68M	Sell	15,300 -5,100	-25%	-$545K	0.01%	1537
2018 Q1	$2.18M	Sell	20,400 -41,500	-67%	-$4.6M	0.01%	1131
2017 Q4	$6.61K	Buy	61,900 +22,000	+55%	+$2.35M	0.03%	527
2017 Q3	$4.44K	Sell	39,900 -20,100	-34%	-$2.15M	0.02%	735
2017 Q2	$6.2K	Buy	60,000 +5,700	+10%	+$561K	0.04%	465
2017 Q1	$5.31K	Sell	54,300 -37,500	-41%	-$3.59M	0.04%	467
2016 Q4	$8.12M	Sell	91,800 -26,100	-22%	-$2.38M	0.06%	244
2016 Q3	$11.4M	Sell	117,900 -37,200	-24%	-$3.54M	0.07%	160
2016 Q2	$13.3M	Buy	155,100 +62,400	+67%	+$5.6M	0.09%	145
2016 Q1	$8.05M	Buy	92,700 +68,100	+277%	+$6.09M	0.07%	252
2015 Q4	$2.78M	Sell	24,600 -32,700	-57%	-$3.55M	0.03%	604
2015 Q3	$5.8M	Sell	57,300 -30,900	-35%	-$3.71M	0.05%	261
2015 Q2	$10.8M	Buy	88,200 +40,500	+85%	+$4.85M	0.11%	141
2015 Q1	$5.46M	Buy	47,700 +24,300	+104%	+$2.68M	0.05%	297
2014 Q4	$2.37M	Buy	23,400 +2,700	+13%	+$262K	0.02%	603
2014 Q3	$1.89M	Buy	20,700 +5,400	+35%	+$474K	0.02%	471
2014 Q2	$1.31K	Buy	15,300 +9,300	+155%	+$733K	0.02%	647
2014 Q1	$474	Sell	6,000 -76,200	-93%	-$6.35M	0.01%	1325
2013 Q4	$6.22M	Buy	82,200 +37,500	+84%	+$2.66M	0.06%	225
2013 Q3	$3.12M	Buy	+44,700	New	+$2.93M	0.03%	398

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Walleye Trading's IBB Position: Q1 2026 in Review

Walleye Trading sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 31,184 shares — an estimated $5.33M sold.

Walleye Trading first reported a position in IBB in Q2 2013 and held it in 36 quarters. The position peaked at $5.26M in Q4 2025. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Walleye Trading reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
Walleye Trading sold 31,184 iShares Biotechnology ETF shares in Q1 2026, an estimated $5.33M.
Walleye Trading first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 36 quarters.
Walleye Trading's iShares Biotechnology ETF position peaked at $5.26M in Q4 2025.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.